+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Everolimus"

From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Pancreatic Cancer Drugs Market Report 2025 - Product Thumbnail Image

Pancreatic Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market Report 2025 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Kidney Cancer Diagnostics and Therapeutics Market Report 2025 - Product Thumbnail Image

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2024 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Medullary Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Medullary Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Thymoma - Pipeline Insight, 2024 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Brain Tumor Drugs Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Brain Tumor Drugs Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
From
From
AFINITOR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AFINITOR Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Breast Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Breast Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator

Everolimus is a drug used in the treatment of breast cancer. It is an mTOR inhibitor, which works by blocking the activity of a protein that helps cancer cells grow and divide. It is used in combination with other drugs to treat advanced or metastatic breast cancer. Everolimus is also used to treat hormone receptor-positive, HER2-negative breast cancer that has spread to other parts of the body. It is typically used in combination with other drugs, such as letrozole or fulvestrant. Everolimus is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of Everolimus include nausea, vomiting, diarrhea, fatigue, and mouth sores. In the Everolimus market, some of the major players include Novartis, Pfizer, AstraZeneca, and Merck. Other companies involved in the market include Amgen, Teva Pharmaceuticals, and Eli Lilly. Show Less Read more